Pathologic Complete Response to Neoadjuvant Therapy in Patients with Pancreatic Ductal Adenocarcinoma Is Associated with Better Prognosis

In patients with pancreatic ductal adenocarcinoma (PDA) who received neoadjuvant therapy and pancreatectomy, pathologic complete response (pCR) is rarely observed and the prognostic significance of pCR is not clear. In this study, we reported 11 patients with pCR (2.5%) from 442 patients with PDA wh...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zhao, Qing, Rashid, Asif, Gong, Yun, Katz, Matthew H., Lee, Jeffrey E., Wolf, Robert, Balachandran, Aparna, Varadhachary, Gauri R., Pisters, Peter W, Wang, Hua, Gomez, Henry F., Abbruzzese, James L., Fleming, Jason B., Wang, Huamin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3832988/
https://ncbi.nlm.nih.gov/pubmed/22050964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.anndiagpath.2011.08.005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak